At the same time, by IHC assay, we observed the elevated expression of MET in tissues from NEPC patients compared to that from either CRPC or primary PCa patients, which exhibited a similar profiling to that of PAX6 (Fig. 7c). Here, MET is linked to posterior cortical atrophy.